Clinical Trial Update: TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study [Phase 2, Phase 3]

View source ↗

Summary

Long-term safety study of TD-1473 in ulcerative colitis was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TD-1473

Snippet

Sponsor: Theravance Biopharma | Conditions: Ulcerative Colitis (UC) | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-11-02